Paris, France

Esther Arranz

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esther Arranz. Retrieved from https://idiyas.com/inventor/esther-arranz-rwc14q3x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Esther Arranz: Innovator in Therapeutic Applications

Introduction

Esther Arranz is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds with therapeutic applications. Her work focuses on enhancing medical treatments through novel chemical formulations.

Latest Patents

Esther Arranz holds a patent for "Derivatives of imidazo[4,5-d]pyridazine, their preparation and their therapeutic application." This invention relates to a compound of formula (I) with various substituents that can be utilized in therapeutic contexts. The patent outlines the preparation processes for these compounds, their intermediates, and their applications as TLR7 and/or TLR8 agonists, including their use in vaccines. She has 1 patent to her name.

Career Highlights

Esther Arranz is currently employed at Sanofi, a leading global healthcare company. Her role involves research and development of new therapeutic agents that can improve patient outcomes. Her expertise in medicinal chemistry has positioned her as a key player in the pharmaceutical industry.

Collaborations

Esther has collaborated with Jidong Zhang, contributing to the advancement of their shared research goals. Their partnership has fostered innovation and has led to the development of promising therapeutic solutions.

Conclusion

Esther Arranz is a dedicated inventor whose work in pharmaceutical innovations continues to impact the field positively. Her contributions, particularly in the area of therapeutic applications, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…